Potassium Chloride Extended Release Tablets
Award Notice Posted
- Solicitation number
- SPE2D2-26-D-0001
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Awarded
- to Avkare LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D2-26-D-0001 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Maple Grove, Minnesota 55369, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical (DLA) awarded contract SPE2D2-26-D-0001 to AvKARE, LLC on October 16, 2025, for the supply of Potassium Chloride Extended Release tablets with an estimated five-year contract value of $39,510,148.75. The contract covers four pharmaceutical items: Potassium Chloride ER 10 MEQ tablets and 20 MEQ tablets, each available in 100-count and 500-count bottles, with unit prices ranging from $5.91 to $50.69 per bottle. The contract is structured with a base year and four option years with identical pricing and estimated quantities, and will be fulfilled through DLA Pharmaceutical Prime Vendor channels to support military and veteran medical supply chains. The products are manufactured by Upsher Smith at facilities in Taiwan and Minnesota, with packaging performed by qualified contractors in Kentucky.
Notice text
SPE2D2-26-D-0001 Potassium Chloride ER Tablets
Awarded contract SPE2D2-26-D-0001 to AvKARE, LLC for 39510148.75 on 2025-10-16.
Files
| File | Type | Posted |
|---|---|---|
| Potassium Chloride - SPE2D2-26-D-0001 - Award - Signed.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Potassium Chloride Extended Release Tablets | Solicitation | |
| Potassium Chloride Extended Release Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity